# Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia

> **NCT03971799** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Center for International Blood and Marrow Transplant Research** · enrollment: 52 (estimated)

## Conditions studied

- Acute Myelogenous Leukemia

## Interventions

- **BIOLOGICAL:** CD33CART autologous
- **BIOLOGICAL:** CD33CART allogeneic

## Key facts

- **NCT ID:** NCT03971799
- **Lead sponsor:** Center for International Blood and Marrow Transplant Research
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-08
- **Primary completion:** 2029-12
- **Final completion:** 2039-12
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2025-07-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03971799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03971799, "Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03971799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*